CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.22369
Abstract: This study was aimed to investigate the correlation between CYP2C19 and ABCB1 polymorphisms and the recurrence of ischemic cardiovascular adverse events in patients with coronary artery disease treated with clopidogrel. read more here.
Keywords: recurrence ischemic; cardiovascular adverse; cyp2c19 abcb1; adverse events ... See more keywords
Photosynthetic symbiotic therapeutics - An innovative, effective treatment for ischemic cardiovascular diseases.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of molecular and cellular cardiology"
DOI: 10.1016/j.yjmcc.2021.11.007
Abstract: Ischemic heart disease is a major cause of global morbidity and mortality, affecting over 15 million patients in the United States. Recent advances in research and innovation have greatly broadened clinicians' ability to treatment ischemic… read more here.
Keywords: heart; treatment ischemic; disease; photosynthetic symbiotic ... See more keywords
Epitranscriptome in Ischemic Cardiovascular Disease: Potential Target for Therapies
Sign Up to like & getrecommendations! Published in 2022 at "Stroke"
DOI: 10.1161/strokeaha.121.037581
Abstract: The global risk of cardiovascular disease, including ischemic disease such as stroke, remains high, and cardiovascular disease is the cause of one-third of all deaths worldwide. The main subjacent cause, atherosclerosis, is not fully understood.… read more here.
Keywords: epitranscriptome ischemic; cardiovascular disease; disease; ischemic cardiovascular ... See more keywords